GHK-Cu 50mg | ≥99% Purity Research Peptide

Within Europe this product is supplied including bacteriostatic water; outside Europe only the compound vial is provided.

For research use only — not for human or veterinary use.

Product Overview

GHK-Cu is a copper-binding tripeptide complex studied in controlled laboratory environments for its role in peptide-mediated signalling pathways, metal-ion interaction dynamics and cellular regulatory modelling. This lyophilized 50 mg preparation is supplied in a sealed research vial and supports reproducible in vitro experimentation.

Compound Overview

GHK-Cu consists of the tripeptide glycyl-L-histidyl-L-lysine complexed with copper. It has been incorporated into laboratory research models examining peptide–metal interactions, extracellular signalling behaviour and regulatory pathway modulation. Its defined molecular structure and stable copper-binding properties make it suitable for controlled biochemical studies.

Scientific Context

Research into copper-binding peptides expanded significantly during the late twentieth century as laboratories explored endogenous regulatory peptides involved in tissue communication and cellular signalling. GHK-Cu has since been used in experimental frameworks investigating peptide-mediated pathway regulation and comparative structure–function analysis under controlled conditions.

Mechanistic Focus in Research

• Copper–peptide interaction analysis
• Cellular signalling pathway modelling
• Metal-ion regulatory research
• Comparative structure–function evaluation
• Controlled in vitro biochemical investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms validation for Batch GF082025022. Key analytical results include:

• Assay Content: 54.0 mg
• Identification – Retention Time: 0.992
• Identification – Spectrum: 997
• Purity: 99.6 percent
• Endotoxins: less than 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures. Results relate only to the tested batch sample.

Research Applications

• Peptide–metal interaction research
• Cellular signalling pathway modelling
• Regulatory peptide evaluation
• Comparative biochemical studies
• Controlled laboratory investigations

Grail Formula Quality

Every Grail Formula research compound undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented materials with batch-number traceability and sealed-vial integrity. EU shipments include sterile bacteriostatic water; outside the EU only the compound vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment
• Supplied for human investigational use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 54.0 mg
Confirmed purity 99.6 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.